Medmen Financial Statements From 2010 to 2024
| MMNFFDelisted Stock | USD 0.0001 0.00 0.00% |
Check Medmen Enterprises financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medmen Enterprises' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medmen financial statements analysis is a perfect complement when working with Medmen Enterprises Valuation or Volatility modules.
Medmen |
Medmen Enterprises Class OTC Stock Profit Margin Analysis
Medmen Enterprises' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Medmen Enterprises Profit Margin | (1.04) % |
Most of Medmen Enterprises' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medmen Enterprises Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Medmen Enterprises Class has a Profit Margin of -1.0368%. This is 90.75% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 18.36% lower than that of the firm.
Medmen Enterprises Class Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medmen Enterprises's current stock value. Our valuation model uses many indicators to compare Medmen Enterprises value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medmen Enterprises competition to find correlations between indicators driving Medmen Enterprises's intrinsic value. More Info.Medmen Enterprises Class is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medmen Enterprises' earnings, one of the primary drivers of an investment's value.About Medmen Enterprises Financial Statements
Medmen Enterprises stakeholders use historical fundamental indicators, such as Medmen Enterprises' revenue or net income, to determine how well the company is positioned to perform in the future. Although Medmen Enterprises investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medmen Enterprises' assets and liabilities are reflected in the revenues and expenses on Medmen Enterprises' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medmen Enterprises Class. Please read more on our technical analysis and fundamental analysis pages.
MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MEDMEN ENTERPRISES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 428 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |